These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20453457)

  • 1. Abdominal migraine associated with ecchymosis of the legs and buttocks: does the symptom imply an unknown mechanism of migraine?
    Kakisaka Y; Wakusawa K; Haginoya K; Uematsu M; Tsuchiya S
    Tohoku J Exp Med; 2010 May; 221(1):49-51. PubMed ID: 20453457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image Gallery: Recurrent headache and facial ecchymosis.
    Garcia-Souto F; Lorente-Lavirgen AI; Martinez-Barranca ML; Coronel-Perez IM
    Br J Dermatol; 2019 Aug; 181(2):e35. PubMed ID: 31240691
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine.
    Burstein R; Levy D; Jakubowski M
    Rev Neurol (Paris); 2005 Jul; 161(6-7):658-60. PubMed ID: 16141951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine?
    Kakisaka Y; Wakusawa K; Haginoya K; Saito A; Uematsu M; Yokoyama H; Sato T; Tsuchiya S
    J Child Neurol; 2010 Feb; 25(2):234-7. PubMed ID: 19509407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Headache: classification, mechanism and principles of therapy, with particular reference to migraine.
    Lance JW
    Recenti Prog Med; 1989 Dec; 80(12):673-80. PubMed ID: 2516913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
    Headache; 2005; 45(7):850-61. PubMed ID: 15985101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic mechanisms of migraine and its acute treatment.
    Edvinsson L; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
    Cady RK; Gutterman D; Saiers JA; Beach ME
    Cephalalgia; 1997 Aug; 17(5):588-90. PubMed ID: 9251874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M; Faulds D
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic mechanisms in vascular headache.
    Moskowitz MA
    Neurol Clin; 1990 Nov; 8(4):801-15. PubMed ID: 2175382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute attack of migraine with sumatriptan].
    González-Espinosa LE; Gómez-Viera N; Olivera-Leal I; Reyes-Lorente R
    Rev Neurol; 1997 Nov; 25(147):1672-5. PubMed ID: 9484515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.